» Articles » PMID: 22328599

ICU Management of Aneurysmal Subarachnoid Hemorrhage

Overview
Publisher Sage Publications
Specialty Critical Care
Date 2012 Feb 14
PMID 22328599
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Aneurysmal subarachnoid hemorrhage (SAH) has very high morbidity and mortality rates. Optimal intensive care unit (ICU) management requires knowledge of the potential complications that occur in this patient population.

Methods: Review of the ICU management of SAH. Level of evidence for specific recommendations is provided.

Results: Grading scales utilizing clinical factors and brain imaging studies can help in determining prognosis and are reviewed. Misdiagnosis of SAH is fairly common so the clinical symptoms and signs of SAH are summarized. The ICU management of SAH is discussed beginning with a focus on avoiding aneurysm re-rupture and securing the aneurysm, followed by a review of the neurologic and medical complications that may occur after the aneurysm is secured. Detailed treatment strategies and areas of current and future research are reviewed.

Conclusions: The ICU management of the patient with SAH can be particularly challenging and requires an awareness of all potential neurologic and medical complications and their urgent treatments.

Citing Articles

Contemporary management of aneurysmal subarachnoid haemorrhage. An update for the intensivist.

Robba C, Busl K, Claassen J, Diringer M, Helbok R, Park S Intensive Care Med. 2024; 50(5):646-664.

PMID: 38598130 PMC: 11078858. DOI: 10.1007/s00134-024-07387-7.


Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview.

Sanicola H, Stewart C, Luther P, Yabut K, Guthikonda B, Jordan J Pathophysiology. 2023; 30(3):420-442.

PMID: 37755398 PMC: 10536590. DOI: 10.3390/pathophysiology30030032.


Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.

Idigo A, Wells J, Brown M, Wiener H, Griffin R, Cutter G Antimicrob Resist Infect Control. 2022; 11(1):95.

PMID: 35836272 PMC: 9284849. DOI: 10.1186/s13756-022-01137-4.


Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH).

Rhim H, Won S, Kashefiolasl S, Brawanski N, Hattingen E, Berkefeld J Sci Rep. 2021; 11(1):8309.

PMID: 33859304 PMC: 8050277. DOI: 10.1038/s41598-021-87863-y.


Approach to the Diagnosis and Management of Subarachnoid Hemorrhage.

Marcolini E, Hine J West J Emerg Med. 2019; 20(2):203-211.

PMID: 30881537 PMC: 6404699. DOI: 10.5811/westjem.2019.1.37352.